|
GADD45GIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13020703906841E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.67660338337805E-11 |
| Normal-vs-Stage2 |
4.725600E-02 |
| Normal-vs-Stage3 |
6.17680000000176E-05 |
| Normal-vs-Stage4 |
6.974100E-04 |
| Stage1-vs-Stage2 |
1.277810E-01 |
| Stage1-vs-Stage3 |
7.996000E-02 |
| Stage1-vs-Stage4 |
9.384000E-01 |
| Stage2-vs-Stage3 |
4.529800E-01 |
| Stage2-vs-Stage4 |
1.331380E-01 |
| Stage3-vs-Stage4 |
1.848200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.27096119687076E-12 |
| Normal-vs-AfricanAmerican |
5.793600E-04 |
| Normal-vs-Asian |
3.305800E-02 |
| Caucasian-vs-AfricanAmerican |
7.470200E-01 |
| Caucasian-vs-Asian |
6.657200E-01 |
| AfricanAmerican-vs-Asian |
8.663200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85940152164221E-12 |
| Normal-vs-Female |
1.805780E-04 |
| Male-vs-Female |
8.818600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.83000000000866E-05 |
| Normal-vs-Extreme_Weight |
3.83190146280299E-11 |
| Normal-vs-Obese |
5.760200E-04 |
| Normal-vs-Extreme_Obese |
3.001900E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.821400E-01 |
| Normal_Weight-vs-Obese |
6.532200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.498200E-01 |
| Extreme_Weight-vs-Obese |
2.844200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.785800E-01 |
| Obese-vs-Extreme_Obese |
9.235800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.246640E-04 |
| Normal-vs-Age(41-60Yrs) |
5.4576999586331E-09 |
| Normal-vs-Age(61-80Yrs) |
2.4677000443063E-09 |
| Normal-vs-Age(81-100Yrs) |
7.481800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.386000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.982800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.864400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.995600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.213600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.878300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64346314335262E-12 |
| Normal-VS-Type2 PRCC |
7.222400E-03 |
| Normal-VS-KIRP CIMP |
1.834200E-02 |
| Normal-VS-Unclassified PRCC |
3.700300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.552340E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.520600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.155800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.356400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.126600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.395800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.45170000149287E-08 |
| Normal-vs-N1 |
2.761900E-04 |
| Normal-vs-N2 |
4.274200E-01 |
| N0-vs-N1 |
8.762000E-01 |
| N0-vs-N2 |
3.117000E-01 |
| N1-vs-N2 |
3.604000E-01 |
|
|
